top of page
Search

NEW #Alzheimer’s Drug Controversy Continues ‣

  • Kai
  • Oct 21, 2021
  • 1 min read

In four papers, #researchers and journalists take on aducanumab's controversial #FDAapproval


Their mission? Analyze what went wrong




 
 
 

Comments

bottom of page